U.S. markets closed
  • S&P 500

    4,567.00
    -88.27 (-1.90%)
     
  • Dow 30

    34,483.72
    -652.22 (-1.86%)
     
  • Nasdaq

    15,537.69
    -245.14 (-1.55%)
     
  • Russell 2000

    2,198.91
    -43.07 (-1.92%)
     
  • Crude Oil

    67.00
    -2.95 (-4.22%)
     
  • Gold

    1,773.30
    -9.00 (-0.50%)
     
  • Silver

    22.86
    +0.01 (+0.06%)
     
  • EUR/USD

    1.1343
    +0.0050 (+0.44%)
     
  • 10-Yr Bond

    1.4430
    -0.0870 (-5.69%)
     
  • GBP/USD

    1.3304
    -0.0008 (-0.06%)
     
  • USD/JPY

    113.1500
    -0.4580 (-0.40%)
     
  • BTC-USD

    57,356.48
    -853.52 (-1.47%)
     
  • CMC Crypto 200

    1,456.40
    +13.62 (+0.94%)
     
  • FTSE 100

    7,059.45
    -50.50 (-0.71%)
     
  • Nikkei 225

    27,821.76
    -462.16 (-1.63%)
     

Royalty Pharma shares soar 57.1% in market debut

  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

June 16 (Reuters) - Shares of Royalty Pharma Plc jumped 57.1% in their stock market debut on Tuesday, as the IPO market gathers steam after the coronavirus crisis stalled potential listings.

Royalty Pharma's shares opened at $44, valuing the company at $26.20 billion.

The company, which buys biopharmaceutical royalties and also helps fund new treatments, sold $2.18 billion in stock after its U.S. initial public offering was priced at the top end of the range, making it the second-largest pharmaceutical listing ever.

(Reporting by C Nivedita; Editing by Vinay Dwivedi)